The approval of Novo Nordisk's (NYSE:NVO)oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 market without requiring investors to choose one specific company.• What should traders watch with XLV?Broad funds like the Health Care Sel... Read more
Benzinga - Dec 23
Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly the problem Eli Lilly (LLY) seems to have cracked with its weight-loss pill. In a late-stage trial, patients switching from weekly injections to Lilly’s oral drug were able to maintain ... Read more
Thestreet - Dec 20
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 31.02% on an annualized basis producing an average annual return of 44.05%. Currently, Eli Lilly has a market capitalization of $951.48 billion. Buying $1000 In LLY: If ...Full story available on Benzinga.com Read more
Benzinga - Dec 15
That added production capacity for Eli Lilly's obesity pill, orforglipron, is crucial as the company races to file for its approval. Read more
Cnbc - Dec 09
On Sunday, Eli Lilly and Co. (NYSE:LLY) shared results from the Phase 3 BRUIN CLL-314 trial of Jaypirca (pirtobrutinib) versus Imbruvica (ibrutinib) in chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who were treatment-naïve or were BTK inhibitor-naïve.Eli Lilly stock is sh... Read more
Benzinga - Dec 08
The race to develop safer, longer lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. Read more
Medical News - Nov 27
Evan Seigerman, BMO head of health care research, joins 'The Exchange' to discuss the gap between Novo Nordisk and Eli Lilly, the valuation gap between the stocks and much more. Read more
Cnbc - Nov 24
The new drug will target weight loss for people with obesity and type 2 diabetes. Read more
Inc - Nov 23
Silicon Valley’s giants crowd the list of the world’s most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of one trillion dollars on Friday, becoming the first business in the health industry to hit that milestone.Lilly’s achievement ... Read more
Fast Company - Nov 21
Eli Lilly and Co (NYSE:LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access.What To Know: Eli Lilly is changing how it sells its well-liked obesity drugs. Instead of sticking to the usual drug‐sales channels... Read more
Benzinga - Nov 21
